We Dissect Protocols

Spss 21

Manufactured by IBM
6 769 citations
Sourced in United States, United Kingdom, Germany, Japan, China, Belgium, Austria, Denmark, Canada, Spain
About the product

SPSS 21.0 is a statistical software package developed by IBM. It is designed to analyze and manipulate data, perform statistical analyses, and generate reports. The core function of SPSS 21.0 is to provide users with a comprehensive suite of tools for data management, analysis, and visualization.

Automatically generated - may contain errors

Market Availability & Pricing

IBM SPSS Statistics 21 has been discontinued and is no longer available for purchase from IBM or its authorized distributors. IBM officially ended marketing for SPSS 21 in 2017, and support concluded in 2019.

While SPSS 21 may still be available on secondary markets, specific pricing information is not readily accessible.

For users seeking current statistical analysis software, IBM offers the latest version, SPSS Statistics 30, which includes enhanced features and support.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

6 769 protocols using «spss 21»

1

Statistical Analysis of Experimental Data

2025
All data were processed using SPSS 21.0 statistical software (IBM, Armonk, NY, USA). Data were expressed as mean ± standard deviation and compared by the t-test or one-way analysis of variance (ANOVA) and Tukey’s post-hoc test. P < 0.05 was considered statistically significant.
+ Open protocol
+ Expand
2

Comparative Statistical Analysis Methods

2025
All the experiments in each group were performed with three replicates. All statistical analyses were processed by GraphPad Prism 8.0 (GraphPad Software, La Jolla, CA, USA) and SPSS 21 (IBM, Armonk, NY, USA). The results of normally distributed data were expressed as mean ± standard deviation and the results of non-normal distribution data were expressed as median and interquartile spacing. In this study, statistical methods such as Student's t-test, one-way ANOVA and two-way ANOVA were applied. When P<0.05, the difference was considered statistically significant.
+ Open protocol
+ Expand
3

Multimodal Flow Assessment for Vessels

2025
The statistical analysis was performed with SPSS 21 (IBM SPSS Statistics, Armonk, NY, USA, https://www.ibm.com). Baseline data for all subjects are expressed as mean ± standard deviation (SD). Peak systolic velocity (PSV), end‐diastolic velocity (EDV), mean flow velocity (MFV), and flow volume were calculated for each site on the left and right side. Comparison of mean flow velocities, flow volumes, and vessel areas (vertical plane) of both sides was conducted using a t‐test for dependent samples. Correlations between the flow velocities measured by RT‐PC flow MRI and nvUS were evaluated by a bivariate Pearson correlation. The p‐values below 0.05 were considered statistically significant.
+ Open protocol
+ Expand
4

Gingival Fluid Inflammatory Markers Analysis

2025
The statistical analysis was performed using Statistic Package for Social Science (SPSS) 21.0 software (IBM, Armonk, NY, USA). Quantitative indicators, including the levels of TNF-α, IL-6, and IL-8 in gingival crevicular fluid for both groups, were represented as mean (± standard deviation). Group comparisons for the above-mentioned quantitative indicators were conducted using the t-test. Patient satisfaction survey data and gender distribution fell under the category of categorical variables. Comparative analyses between the two groups for these variables were carried out using the chi-square test or non-parametric tests. A significance level of P<0.05 was considered as statistically significant differences.
+ Open protocol
+ Expand
5

Investigating Cellular Stress Response

2025
All experiments were carried out at least three times with the description of mean ± standard deviation. The significant difference (P < 0.05) was identified with one-way ANOVA and the Duncan test by SPSS software (SPSS 21, IBM, USA).
+ Open protocol
+ Expand

Top 5 most cited protocols using «spss 21»

1

Prognostic Impact of Risk Stratification in Multiple Myeloma

An explorative analysis of the 3060 patients for whom ISS, CA and LDH data were simultaneously available was conducted. The K-adaptive partitioning,25 dedicated to censored survival data (minimax-based partitioning rule by log-rank test), was used for ISS/CA/LDH grouping: this routine gave an optimal number of three subgroups: the R-ISS I, II and III. The OS and PFS curves were estimated by the Kaplan-Meier method and compared by the log-rank test. OS and PFS were then analyzed through the Cox proportional hazards model, comparing the following risk factors by the Wald test: age at diagnosis (≤65 vs >65 years), gender (male vs female), iFISH (high-risk vs standard-risk CA), LDH (high vs normal), ISS (II vs I and III vs I) and R-ISS grouping as defined by the recursive partitioning procedure. The effects of the baseline features (age, gender and R-ISS) were also assessed by the multivariate Cox model; as in the univariate analysis, the R-ISS stage was treated as time-dependent variable. Subgroup analyses of PFS and OS were performed to confirm the effect of R-ISS in different subgroups of patients, that is in patients older and younger than 65 years of age, and in patients receiving ASCT or not, those receiving PI or not and those receiving IMIDs or not. Patients characteristics were tested using the Fisher’ exact test for categorical variables and the Mann-Whitney test for continuous ones. All reported p-values were two-sided, at the conventional 5% significance level. Data were analyzed as of December 2014 by R 3.0.1 package kaps and IBM SPSS 21.0.0.
+ Open protocol
+ Expand

Corresponding organizations : Ospedali Riuniti di Ancona, Institut Claudius Regaud, Vrije Universiteit Amsterdam, Universitat de Barcelona, Alfred Health, Mayo Clinic, Lymphoma Research Foundation, Centre Hospitalier Universitaire de Nantes

2

Prognostic Value of Albumin and Lymphocyte-Monocyte Ratio

Analysis was performed with SPSS 21.0 (IBM Corporation, Armonk, NY, USA) and R software version 3.0.2 and the ‘rms' package (R Foundation for Statistical Computing, Vienna, Austria). Pearson χ2-test or Fisher's exact test was used to compare categorical variables and continuous variables were analysed by Wilcoxon rank-sum test or Kruskal–Wallis test. The Kaplan–Meier method with log-rank test was used to compare survival curves. The Cox proportional hazards regression model was applied to perform univariate and multivariate analyses, and those variables that achieved statistical significance in the univariate analysis were entered into the multivariable analysis. We first evaluated these haematological and laboratory markers including NLR, PLR, LMR, haemoglobin and serum albumin as continuous variables, together with traditional clinicopathological variables in the univariate and multivariate analyses, and identified that LMR and serum albumin were independent prognostic factors of OS. Next, the two markers were analysed as categorical variables. Dichotomisation of serum albumin was based on the lower range of normal measurement at 40 g l−1 (normal range, 40–55 g l−1). Owing to no widely accepted cutpoint of LMR, we used the median value at 4.44 as the cutoff for dichotomisation. The SIS was established based on the combination of different serum albumin and LMR levels. The SIS as well as traditional clinicopathological variables was assessed in the multivariate analysis. A nomogram was created by R software using ‘rms' package. Calibration plots were generated to examine the performance characteristics of the predictive nomogram. The Harrell's Concordance index (C-index) was used to quantify the predictive accuracy (Harrell et al, 1996 (link)), which ranges from 0.5 (no predictive power) to 1 (perfect prediction). All statistical tests were two-sided and were performed at a significance level of 0.05.
+ Open protocol
+ Expand

Corresponding organizations : Zhongshan Hospital, Fudan University, Shanghai Medical College of Fudan University

3

Investigating APOE ε4 and Alzheimer's Biomarkers

For the initial analyses, we evaluated the effect of diagnosis and APOE ε4 status on target measures using two-way ANCOVA for continuous variables and a chi-square test for categorical variables implemented in SPSS 21.0 (SPSS Statistics 21, IBM Corporation, Somers, NY). Post-hoc analyses used a Bonferroni correction for multiple comparisons. Specifically, the effects of diagnosis, APOE ε4 carrier status, and their interaction on demographics, clinical and psychometric test performance, patient and informant cognitive complaints, regional amyloid deposition ([18F]Florbetapir SUVR), regional glucose metabolism ([18F]FDG SUVR), brain atrophy (hippocampal volume and entorhinal cortex thickness), and CSF levels of Aβ1–42, t-tau, and p-tau were assessed. We tested for normality of the evaluated measures and found that the measures of CSF amyloid and tau, [18F]Florbetapir SUVR, and entorhinal cortex thickness were not normally distributed. We log-transformed these variables and repeated the above analyses. However, this log-transformation did not alter the findings observed with the raw variables. Therefore, we present the findings obtained by analysis of the raw values in the present report. A further targeted analysis in SMC participants of an interaction between APOE ε4 carrier status and amyloid positivity established using [18F]Florbetapir PET scans (cutoff of 1.52 in the global cortical ROI was selected due to maximal classification of AD vs CN patients in the full ADNI-GO/2 sample and amyloid positive vs. negative defined using a previously reported cutoff [45 (link)]) was completed. Specifically, a two-way ANCOVA was used to evaluate the effect of APOE ε4 status, amyloid positivity, and their interaction on CSF levels of Aβ1–42, t-tau, and p-tau. All PET and CSF biomarker analyses were covaried for age and gender. Analyses of cognition were covaried for age, gender, and years of education. Finally, analyses of brain atrophy were covaried for age, gender, and total intracranial volume (ICV). Given the known association of depressive symptoms with subjective cognitive decline, we repeated the analyses including the total score of the Geratric Depression Scale (GDS) as a covariate. Inclusion of the GDS total score as a covariate did not change any of the observed results and thus, is not included in the final results presented in the present report.
+ Open protocol
+ Expand

Corresponding organizations : Indiana University – Purdue University Indianapolis, Mayo Clinic in Arizona, University of California, Davis, University of California, San Diego, University of Michigan–Ann Arbor, University of California, Berkeley, University of Pennsylvania, University of California, San Francisco, San Francisco VA Medical Center

4

Multivariate Analysis of SPSS Data

Statistical analysis used IBM SPSS 21.0.
+ Open protocol
+ Expand

Corresponding organizations : University of Cambridge, Royal College of General Practitioners, University College London

5

Neuroanatomical Variability and ICV Correction

All statistical data were analyzed in SPSS 21.0 (IBM Corp., Armonk, NY, USA). Scatterplots of each raw neuroanatomical structure volume vs. ICV were created for men and women combined with a superimposed regression line with corresponding confidence intervals. Independent-sample t-tests were run to determine if there were differences in age, ICV, height, and diastolic blood pressure (DBP) between men and women. The participants were stratified in 11 groups according to their ICV, starting from 1000 ml and increasing with 100 ml up to 2100 ml. One-Way ANOVAs were run to determine if the proportion (relative size) of the four different brain tissue types (cortical gray matter, white matter, subcortical gray matter and the ventricles) were different for groups with different ICVs. Two-Way ANOVAs were run to examine the effects of sex and ICV on the relative size of cortical and subcortical gray matter, white matter and the ventricles.
The proportions and residuals methods described above were performed on the ICV-matched subsample and the whole sample. The proportions and residuals methods were also applied to the men- and women-only small vs. large ICV subsamples. To test for significant main effect of sex, as well as sex*age and sex*ICV interactions, General linear models (GLMs) were used with age, sex and ICV as between subjects factors and neuroanatomical structure as within-subjects factor. Each neuroanatomical structure was tested separately and the significance threshold was set at p < 0.05, corrected for multiple comparisons using the Bonferroni-Holm method. These analyses were first performed on the neuroanatomical volumes obtained in the ICV-matched subsample, then the raw volumes and the volumes obtained from the different ICV-correction methods in the entire sample, and finally in the men- and women-only small vs. large ICV subsamples. Subsequently, post-hoc t-tests were run to investigate sex differences between the neuroanatomical volumes. The significance threshold was set at p < 0.05, corrected for multiple comparisons using the Bonferroni-Holm method. Boxplots of the standardized residuals for all neuroanatomical structures in the ICV-matched subsample and the different ICV-corrected data were created for men and women separately, and in the men- and women-only small vs. large ICV subsamples boxplots were created for the small and large ICV-groups separately. Lastly, to investigate which ICV-correction method had the best match with the ground truth, i.e., the ICV-matched subsample, a Spearman's rank-order correlation was run between the mean standardized volumes for all 18 neuroanatomical structures obtained with the proportions and residuals method and the ICV-matched subsample.
+ Open protocol
+ Expand

Corresponding organizations : St Olav's University Hospital, Norwegian University of Science and Technology

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Protocol search & design
(papers, patents, application notes)
2. Protocol validation
(from literature and MDAR)
3. Lab Product search
4. Product validation from literature
5. Troubleshoot product/ protocol
6. Instant figure generation New
Want to copy this response? Create your account to unlock copy/paste and export options.